Abstract:Background: Colon cancer (CC) is a highly prevalent malignancy worldwide, characterized by elevated mortality rates and poor prognosis. N7-methylguanosine (m7G) methylation is an emerging RNA modification type and involved in the development of many tumors. Despite this, the correlation between m7G-related miRNAs and CC remains to be elucidated. This research aimed to investigate the clinical significance of m7G-related miRNAs in predicting both the prognosis and tumor microenvironment (TME) of CC. Method: We retrieved transcriptome data and associated clinical information from a publicly accessible database. Using univariate Cox and LASSO regression analyses, we established a signature of m7G-related miRNAs. Additionally, we used CIBERSORT and ssGSEA algorithms to explore the association between the prognostic risk score and the TME in CC patients. By considering the risk signature and immune infiltration, we identified differentially expressed genes that contribute to the prognosis of CC. Finally, the expression patterns of prognostic miRNAs were verified using quantitative reverse transcriptase PCR (qRT-PCR) in cell lines. Results: We constructed a prognostic risk signature based on seven m7G-related miRNAs (miR-136-5p, miR-6887-3p, miR-195-5p, miR-149-3p, miR-4433a-5p, miR-31-5p, and miR-129-2-3p). Subsequently, we observed remarkable differences in patient outcomes between the high- and low-risk groups. The area under the curve (AUC) for 1-, 3-, and 5-year survivals in the ROC curve were 0.735, 0.707, and 0.632, respectively. Furthermore, our results showed that the risk score can serve as an independent prognostic biomarker for overall survival prediction. In terms of immune analysis, the results revealed a significant association between the risk signature and immune infiltration, as well as immune checkpoint expression. Finally, our study showed that CCDC160 and RLN3 is the gene most relevant to immune cells and function in CC. Conclusion: Our study conducted a comprehensive and systematic analysis of m7G-associated miRNAs to construct prognostic profiles of CC. We developed a prognostic risk model based on m7G-miRNAs, with the resulting risk scores demonstrating considerable potential as prognostic biomarkers. These findings provide substantial evidence for the critical role of m7G-related miRNAs in colon cancer and may offer new immunotherapeutic targets for patients with this disease.

Up-Regulated Expression of MCM 7 is a Poor Prognostic Factor in Colorectal Cancer

The prognostic index of m7G-related genes in CRC correlates with immune infiltration

Establishment of m7G-related gene pair signature to predict overall survival in colorectal cancer

A Novel m7G-Related Gene Signature Predicts the Prognosis of Colon Cancer

The m7G-Related Long Noncoding RNA Signature Predicts Prognosis and Indicates Tumour Immune Infiltration in Colon Cancer

Prognostic Significance of Matrix Metalloproteinase 7 Immunohistochemical Expression in Colorectal Cancer: a Meta-Analysis.

N6-methyladenosine Related Gene Expression Signatures for Predicting the Overall Survival and Immune Responses of Patients with Colorectal Cancer

MCM7 Expression is Correlated with Histological Subtypes of Lung Adenocarcinoma and Predictive of Poor Prognosis.

A novel m7G-related miRNA prognostic signature for predicting clinical outcome and immune microenvironment in colon cancer

A novel m7G-related lncRNA risk model for predicting prognosis and evaluating the tumor immune microenvironment in colon carcinoma

MCM7 Promotes Cancer Progression Through Cyclin D1-dependent Signaling and Serves As a Prognostic Marker for Patients with Hepatocellular Carcinoma.

miR-107 regulates the effect of MCM7 on the proliferation and apoptosis of colorectal cancer via the PAK2 pathway

Expression of Chemokine Receptor CXCR7 in Colorectal Carcinoma and Its Prognostic Significance.

High expression of CDCA7 predicts tumor progression and poor prognosis in human colorectal cancer

MCM7 Amplification and Overexpression Are Associated with Prostate Cancer Progression

Function and mechanism of MCM8 in the development and progression of colorectal cancer

Change of CMTM7 expression, a potential tumor suppressor, is associated with poor clinical outcome in human non-small cell lung cancer

Prognostic and clinical significance of the proliferation marker MCM7 in breast cancer

MCM8 promotes gastric cancer progression through RPS15A and predicts poor prognosis

Systemic Analysis of the DNA Replication Regulator MCM Complex in Ovarian Cancer and Its Prognostic Value

A Seven-Gene Signature Predicts Overall Survival of Patients with Colorectal Cancer